Analysis for EXC
- 📈 Growth — 22/30
- 💰 Profitability — 18/20
- 🏦 Financial Health — 6/20
- 💵 Valuation — 10/20
- ⚠️ Risk — 7/10
Overall Score: 66/100
Summary:
📈 Growth & Financial Trajectory
Eight quarters show revenues moving from about $5.36B (2024 Q2) to $7.24B (2026 Q1), with mid-period dips in 2025 Q2 and 2024 Q4. Net income grew from about $448M to $919M. Operating margins held in the ~21-23% range, signaling stable operating leverage despite quarterly swings.
Eight-quarter trend suggests positive revenue scale and earnings growth, but seasonality and sector cyclicality temper the pace.
💰 Margins & Cash Flow
- Operating margin around 21-23%; Q2 2025 dips to about 17%.
- Operating cash flow generally positive, with peaks near $2.30B (2025 Q3) and $1.72B (2026 Q1).
- Investing cash flow typically negative (~-$1.6B to -$2.0B); financing provides modest inflows.
🛡️ Balance Sheet & Liquidity
Total assets around $111-118B; liabilities around $83-88B; equity around $26-29B. Current ratio runs near 0.9–1.0 and leverage about 3x; liquidity cushion is modest.
⚠️ Key Drivers & Risks
- Drivers: regulated framework, stable demand, and ongoing transmission/capex.
- Risks: leverage and interest-rate sensitivity; regulatory/regulatory changes and weather/cycle exposure.